|
Index of reports
> Cases resulting in a serious event (287)
> Cases with Liver Disorder (21)
Below is the selection of adverse event reports related to Lamisil (Terbinafine) that includes cases resulting in a serious event where reactions include liver disorder.
Adverse event in 58 year old female receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-10-19
Patient: 58 year old female
Adverse reactions / side effects: Weight Decreased, Drug Toxicity, Liver Injury, Hepatotoxicity, Cholestasis, Hepatitis, Liver Disorder
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in 58 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-10-16
Patient: 58 year old male
Adverse reactions / side effects: Pancreatitis Acute, Abdominal Pain, Jaundice, Bile Duct Obstruction, Pruritus, Liver Disorder, Pancreatic Disorder, Hepatobiliary Disease, Bile Duct Stenosis, Biliary Drainage, Urine Colour Abnormal, Alcoholic Pancreatitis, Intestinal Functional Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Benicar; Norvasc; Probenecid; Zetia; Prevacid
Adverse event in 49 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-07-26
Patient: 49 year old male
Adverse reactions / side effects: Abdominal Pain, Asthma, Nasopharyngitis, Pruritus, Tongue Discolouration, Leukoplakia, Pyrexia, Appetite Disorder, Enterococcal Sepsis, DRY Mouth, Hiccups, Biopsy Liver, Blood Creatinine Increased, Cough, Chest Discomfort, Anaemia, Hypotension, Chromaturia, Nasal Congestion, Rhinitis Allergic, Bronchitis Chronic, Anorexia, Ocular Hyperaemia, Ocular Icterus, Sputum Discoloured, Jaundice, Hyperbilirubinaemia, Food Intolerance, Eye Irritation, Wheezing, Chills, Drug Interaction, Liver Disorder, Liver Transplant, Fatigue, Haematocrit Decreased, Hepatorenal Syndrome, Pharyngolaryngeal Pain, Chronic Hepatic Failure, Pharyngitis, Renal Failure Acute, Dyspnoea, Hepatic Pain, Vomiting, Nausea, Tongue Coated, Hepatic Enzyme Increased, Haematochezia, Haemoglobin Decreased, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Biaxin XL
Start date: 2005-04-12
Lamisil
Dosage: 250 mg, qd
Administration route: Oral
Indication: Tinea Pedis
Start date: 2005-01-20
End date: 2005-05-01
Other drugs received by patient: Antihypertensives; Lotrel; Nizoral; Decadron; Astelin; Nasonex; Flonase
Adverse event in 58 year old female receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-07-26
Patient: 58 year old female, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Henoch-Schonlein Purpura, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Liver Disorder
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in 49 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-07-26
Patient: 49 year old male
Adverse reactions / side effects: Abdominal Pain, Asthma, Nasopharyngitis, Pruritus, Tongue Discolouration, Leukoplakia, Pyrexia, Appetite Disorder, Enterococcal Sepsis, DRY Mouth, Hiccups, Biopsy Liver, Blood Creatinine Increased, Cough, Chest Discomfort, Anaemia, Hypotension, Chromaturia, Nasal Congestion, Rhinitis Allergic, Bronchitis Chronic, Anorexia, Ocular Hyperaemia, Ocular Icterus, Sputum Discoloured, Jaundice, Hyperbilirubinaemia, Food Intolerance, Eye Irritation, Wheezing, Chills, Drug Interaction, Liver Disorder, Liver Transplant, Fatigue, Haematocrit Decreased, Hepatorenal Syndrome, Pharyngolaryngeal Pain, Chronic Hepatic Failure, Pharyngitis, Renal Failure Acute, Dyspnoea, Hepatic Pain, Vomiting, Nausea, Tongue Coated, Hepatic Enzyme Increased, Haematochezia, Haemoglobin Decreased, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Biaxin XL
Start date: 2005-04-12
Lamisil
Dosage: 250 mg, qd
Administration route: Oral
Indication: Tinea Pedis
Start date: 2005-01-20
End date: 2005-05-01
Other drugs received by patient: Antihypertensives; Lotrel; Nizoral; Decadron; Astelin; Nasonex; Flonase
Adverse event in 58 year old female receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-07-10
Patient: 58 year old female, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Henoch-Schonlein Purpura, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Liver Disorder
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in 58 year old male receiving Lamisil (Terbinafine)
Reported by a individual with unspecified qualification from United States on 2007-07-06
Patient: 58 year old male
Adverse reactions / side effects: Jaundice, Abdominal Pain, Bile Duct Obstruction, Condition Aggravated, Liver Disorder, Pancreatic Disorder, Biliary Drainage, Intestinal Functional Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Benicar; Norvasc; Probenecid; Zetia; Prevacid
Adverse event in 49 year old male receiving Lamisil (Terbinafine)
Reported by a physician from United States on 2007-05-29
Patient: 49 year old male
Adverse reactions / side effects: Abdominal Pain, Asthma, Nasopharyngitis, Pruritus, Tongue Discolouration, Leukoplakia, Pyrexia, Appetite Disorder, DRY Mouth, Hiccups, Biopsy Liver, Blood Creatinine Increased, Cough, Chest Discomfort, Hypotension, Anaemia, Chromaturia, Nasal Congestion, Rhinitis Allergic, Bronchitis Chronic, Anorexia, Ocular Hyperaemia, Ocular Icterus, Sputum Discoloured, Jaundice, Food Intolerance, Hyperbilirubinaemia, Eye Irritation, Wheezing, Chills, Drug Interaction, Liver Disorder, Liver Transplant, Haematocrit Decreased, Fatigue, Hepatorenal Syndrome, Pharyngolaryngeal Pain, Chronic Hepatic Failure, Pharyngitis, Renal Failure Acute, Dyspnoea, Hepatic Pain, Vomiting, Nausea, Rhinorrhoea, Tongue Coated, Hepatic Enzyme Increased, Haemoglobin Decreased, Haematochezia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Biaxin XL
Start date: 2005-04-12
Lamisil
Dosage: 250 mg, qd
Administration route: Oral
Indication: Tinea Pedis
Start date: 2005-01-20
End date: 2005-05-01
Other drugs received by patient: Antihypertensives; Lotrel; Nizoral; Decadron; Astelin; Nasonex; Flonase
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-04-02
Patient: 81 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Malaise, Hepatic Encephalopathy, C-Reactive Protein Increased, Melaena, Blood Creatinine Increased, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Metabolic Acidosis, Haemodialysis, Heart Rate Decreased, Micturition Disorder, Bacteraemia, Aspartate Aminotransferase Increased, Septic Shock, Jaundice, Drug Interaction, Cholestasis, Liver Disorder, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Bacterial Infection, Tachypnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemoglobin Decreased, Renal Failure, Respiratory Acidosis, Blood Pressure Decreased, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 48 year old male receiving Lamisil (Terbinafine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-03-26
Patient: 48 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Blood Glucose Decreased, Blood Alkaline Phosphatase Increased, Gamma-Glutamyltransferase Increased, LOW Density Lipoprotein Decreased, Alanine Aminotransferase Increased, Blood Triglycerides Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Dogmatyl; Lendormin; Luvox; Pursennid; Magnesium Oxide; Laxoberon; Mentax; Clarithromycin; Myslee; Petrolatum Salicylicum; Potassium Chloride W / Sodium Chloride
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-03-08
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-03-05
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-02-16
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
End date: 2006-12-25
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in 48 year old male receiving Lamisil (Terbinafine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-02-14
Patient: 48 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Blood Glucose Decreased, Blood Alkaline Phosphatase Increased, Gamma-Glutamyltransferase Increased, LOW Density Lipoprotein Decreased, Alanine Aminotransferase Increased, Blood Triglycerides Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Dogmatyl; Lendormin; Luvox; Pursennid; Magnesium Oxide; Laxoberon; Mentax; Clarithromycin; Myslee; Petrolatum Salicylicum; Potassium Chloride W / Sodium Chloride
Adverse event in 80 year old female receiving Lamisil (Terbinafine)
Reported by a individual with unspecified qualification from Japan on 2007-02-13
Patient: 80 year old female, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Pruritus, Skin Exfoliation, Blood Albumin Decreased, Pyrexia, Eczema, Erythema, Liver Disorder, Acute Generalised Exanthematous Pustulosis, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Neutrophil Percentage Increased, Rash Pustular, Alanine Aminotransferase Increased, Pustular Psoriasis, Aspartate Aminotransferase Increased, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Fosamax; Aspara-CA; Onealfa
Adverse event in 81 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-02-09
Patient: 81 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Respiratory Disorder, Blood Bilirubin Unconjugated Increased, Cholestasis, Drug Interaction, Liver Disorder, Haematocrit Decreased, Hepatic Encephalopathy, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Tachypnoea, Bacterial Infection, Blood Creatinine Increased, Melaena, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Haemodialysis, Haemoglobin Decreased, Renal Failure, Heart Rate Decreased, Respiratory Acidosis, Bacteraemia, Micturition Disorder, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient possibly interacting with the suspect drug:
Warfarin Potassium
Dosage: 2.5 mg/d
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2005-11-12
Other drugs received by patient: Tofisopam; Hibon; Fujismin; Nitorol; Magnesium Oxide; Clarithromycin; Epinastine Hydrochloride; Vitamin B6; Vitamin B-12; Celestone; Solon
Adverse event in female receiving Lamisil (Terbinafine)
Reported by a physician from Belgium on 2007-01-30
Patient: female
Adverse reactions / side effects: Vomiting, Nausea, Chromaturia, Gastroenteritis, Liver Disorder, Faeces Discoloured
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in female receiving Lamisil (Terbinafine)
Reported by a physician from Belgium on 2007-01-30
Patient: female
Adverse reactions / side effects: Vomiting, Nausea, Chromaturia, Gastroenteritis, Liver Disorder, Faeces Discoloured
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in 49 year old female receiving Lamisil (Terbinafine)
Reported by a consumer/non-health professional from United States on 2007-01-29
Patient: 49 year old female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Nausea, Pyrexia, Headache, Liver Disorder, Abdominal Pain Upper, Faeces Pale, Visual Disturbance, Blood Potassium Decreased, Liver Function Test Abnormal, Urine Colour Abnormal, Pharyngolaryngeal Pain, Bacterial Infection, Immune System Disorder, Influenza Like Illness, Inflammation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in female receiving Lamisil (Terbinafine)
Reported by a physician from Belgium on 2007-01-29
Patient: female
Adverse reactions / side effects: Chromaturia, Gastroenteritis, Liver Disorder, Faeces Discoloured
Suspect drug(s):
Lamisil (Terbinafine)
Adverse event in 56 year old male receiving Lamisil (Terbinafine)
Reported by a physician from Japan on 2007-01-25
Patient: 56 year old male, weighing 81.0 kg (178.2 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pyrexia, Headache, Liver Disorder, Malaise, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Anorexia, Aspartate Aminotransferase Increased
Suspect drug(s):
Lamisil (Terbinafine)
Other drugs received by patient: Norvasc; Blopress; Pantosin; Juvela; Gasmotin
|
